Product Description
| Brand |
Snibe |
| Sample Type |
Serum |
| Pack Size |
100T |
| CAT No. |
130201014M |
| Application |
Cancer Marker |
The kit has been designed for the quantitative determination of Cancer Antigen 242 (CA 242) in human serum. The method can be used for samples over the range of 0.5-200.0U/ml. The test has to be performed on the Fully-auto chemiluminescence immunoassay (CLIA) analyzer MAGLUMI (Including Maglumi 600,Maglumi 1000,Maglumi 1000 Plus, Maglumi 2000,Maglumi 2000 Plus,Maglumi 3000 and Maglumi 4000).
High Throughput PerformanceCapable of processing up to 180 tests per hour with an incubation time of only 18 minutes, the Snibe MAGLUMI CA 242 ensures rapid turnaround for high-volume clinical laboratories. This efficiency supports swift decision-making and maximizes productivity in busy diagnostic settings.
Reliable Data Management and Quality ControlEquipped with integrated barcode scanning, extensive data storage for up to 100,000 results, and both internal and external QC compatibility, the analyzer guarantees robust traceability and result reliability. Multi-point calibration further enhances accuracy and reproducibility, meeting strict clinical standards.
User-Friendly and Versatile OperationThe system utilizes an intuitive LCD touch screen interface and supports connectivity through RS232 and USB ports. With real-time operation, advanced electronics, and medical-grade materials, the analyzer provides a dependable and seamless user experience. Its automated operation keeps hands-on time minimal for laboratory personnel.
FAQ's of Snibe MAGLUMI CA 242 (CLIA):
Q: How does the Snibe MAGLUMI CA 242 (CLIA) analyzer operate for CA 242 tumor marker testing?
A: The analyzer uses chemiluminescence immunoassay (CLIA) technology to quantitatively measure CA 242 levels in human serum or plasma. After a sample is loaded, the fully automated system manages incubation, detection, and data processing, delivering results in as little as 18 minutes per test cycle.
Q: What sample volumes and types are compatible with the analyzer?
A: The instrument can process serum or plasma samples, accommodating sample volumes between 10-80 L. This flexibility supports a variety of clinical needs and accommodates different patient populations.
Q: When should calibration and quality control be performed on the device?
A: Calibration, using two-point or multi-point methods, should be done according to laboratory protocols or when prompted by the analyzer after a reagent lot change. Both internal and external quality controls should be regularly performed to ensure result accuracy and system reliability.
Q: Where can this equipment be installed and what are its environmental requirements?
A: The analyzer is designed for bench-top installation in clinical laboratories. It should be operated in environments with temperatures between 15-30C and relative humidity 85%, ensuring stable and optimal performance.
Q: What is the process for data management and retrieval on this analyzer?
A: Test results are automatically stored in the analyzer's memory, which can hold up to 100,000 sample results. Results can be easily retrieved, reviewed, and exported via RS232 or USB interfaces, supporting laboratory information system (LIS) integration if needed.
Q: How does the analyzer benefit clinical laboratories in India?
A: It delivers high-throughput, rapid, and accurate tumor marker testing, streamlining laboratory workflows and supporting timely clinical decisions. Its ease of use, robust quality control, and compliance with demanding standards make it suitable for diverse clinical laboratory settings across India.